DLA Piper advises Quantum-Si in pricing of US$50 million of common stock

DLA Piper advised Quantum-Si Incorporated, a biotechnology company focused on the growing field of proteomics, in the pricing of US$50 million registered direct offering of common stock.

Quantum-Si entered into an agreement with a single institutional investor for the purchase and sale of 29,940,119 shares of common stock (and common stock equivalents) at a purchase price of US$1.67 per share. The company intends to use the net proceeds from the offering for working capital and general corporate purposes.

The DLA Piper team was led by Partner Larry Nishnick (San Diego) and included Associates Bianca LaCaille (Seattle), Katerina Karaoglanova, and Melody Lilazy (both San Diego).

With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm is an active advisor in public company securities offerings. In addition to these capital markets transactions, DLA Piper has been rated number one in global M&A volume for 15 consecutive years, according to Mergermarket, and ranked as a top five most active VC legal advisor in the US and number one in VC, PE and M&A in combined global deal volume according to PitchBook.